Abstract: Heme oxygenase-1 (HO-1) is the rate limiting enzyme in heme catabolism and degrades heme to carbon monoxide, biliverdin, and ferrous iron. HO-1 transcriptional induction occurs in response to multiple forms of chemical, physical stress and cytokines. HO-1 confers cytoprotection by inhibiting apoptosis, oxidative stress, and inflammation. Hepatitis C virus (HCV) is a major cause of cirrhosis and hepatocellular carcinoma. It has been shown that HO-1 induction and HO-1 products interfere with replication of HCV and markedly decreased HCV replication. However, a growing body of evidence indicates that induction of HO-1 may be involved in carcinogenesis and can play a role in the metastasis and growth of tumors. The antioxidant, antiviral activity of HO-1 makes it the cytoprotective enzyme for liver tissue in HCV infection, and induction of HO-1 can be suggested as a future therapeutic approach. However, the role of HO-1 in tumor growth should not be ignored.
Introduction
Heme oxygenase (HO, EC 1.14.99.3) -also known as heat-shock protein (HSP) 32 -is the rate-controlling enzyme of heme catabolism. This microsomal enzyme acts on the α-methene bridge of heme moiety to produce equimolar amounts of carbon monoxide, bilirubin, and iron (Abraham et al. 1987) (Fig. 1 ). There are three known isoforms of HO, termed HO-1, 2, and 3 (Tenhunen et al. 1969; McCoubrey et al. 1997; Shan et al. 2007 ). Among these isoforms, HO-2 is known to maintain the basal HO activity, while HO-1 is the highly inducible form (Abraham et al. 1987) . HO-1 is highly expressed in liver and spleen, and many cancer cells (Jozkowicz et al. 2007 ). HO-1 could be up-regulated markedly by a variety of stressful stimuli, such as physical stress, reactive oxygen species (ROS), UV irradiation, and bacterial endotoxins, as well as by heme or certain other metalloporphyrins, particularly, cobalt protoporphyrin (Shan et al. 2007; Ryter et al. 2006) .
Heme oxygenase and oxidative stress
Heme is a double-edged sword. It is the main component of hemoglobin, therefore, it is important for oxygen transportation. However, it may catalyze the production of cytotoxic ROS when it reacts with molecular oxygen. As demonstrated in Figure 1 , heme degradation by HO-1 results in the production of CO, biliverdin and free iron (Fe 2+ ). Carbon monoxide is analogous to nitrogen monoxide that activates guanylate cyclase (GC); an important factor that relaxes vascular systems (Vile & Tyrrell 1993; Jenner et al. 2002) . In addition, CO was shown to suppress apoptosis and the synthesis of proinflammatory cytokines, NO, and prostaglandins (Otterbein et al. 2000; Morse et al. 2003) .
In the normal iron recycling pathway, Fe 2+ removed from cells is stored as ferritin, a multimeric ironchelating protein. By doing so, ferritin limits the generation of free radicals from free Fe 2+ by Fenton reaction (Vile & Tyrrell 1993; Kehrer 2000) .
The other important product of HO-1 is biliverdin. Biliverdin is converted to bilirubin by the action of biliverdin reductase. Both biliverdin and bilirubin are thought to play an antioxidant role that contribute in the overall protective effect of HO-1 (Stocker et al. 1987a,b) (Fig. 1) production and more reactive molecules (Fig. 1) . Induction of the HO-1 isoenzyme increases the rate of free heme catabolism, and induces Fe 2+ storage as ferritin, and thus preventing it from inducing cell and protein damage and programmed cell death in response to proinflammatory agonists (O'Connell et al. 2004; Lang et al. 2005; Seixas et al. 2009 ).
Heme oxygenase-1 and inflammation
It has been shown that HO-1 is a multifunctional protein that plays anti-inflammatory, anti-apoptotic and antiproliferative actions (Lee & Chau 2002; Pae et al. 2004a ). The anti-inflammatory role of HO-1 has been widely described in literature. Multiple oxidative stress and inflammation transcription factors have a binding site on the HO-1 promotor, among them are AP-1, NF-κB, and AP-2, as well as glucocorticoid-responsive elements (Lavrovsky et al. 1994 (Lavrovsky et al. , 2000 Lee & Chau 2002) . In addition, HO-1 has been shown to suppress JNK-signaling pathway; a known MAPK/AP-1 pathway that is activated in inflammation and oxidative stress (Conde de la Rosa et al. 2008) . In HO-1-deficient mice, chronic inflammatory state was developed and mice showed increased susceptibility to organ damage by lipopolysaccharide (LPS) (Wijayanti et al. 2005; Poss & Tonegawa 1997) . The anti-inflammatory and cytoprotective functions of HO-1 were shown in acute lung injury. Following LPS challenge, treatment with cobalt protoporphyrin (CoPP), the specific HO-1 inducer, results in a remarkable reduction in inflammatory cell infiltration in lung tissues (Shan et al. 2007 ).
The anti-inflammatory role of HO-1 extends to the reactive nitrogen species (RNS)/NO system by inhibiting NO production in endotoxic shock. HO-1 expression attenuates the endotoxin-induced expression of iNOS and cationic amino acid transporter (CAT-2) isozymes in septic rat and thus reduces increases in NO production and L-arginine transport (Huang et al. 2008) .
Knowing that more than 80% of endogenous CO production comes from heme metabolism -the remaining fraction is produced from other metabolic processes, such as lipid oxidation and xenobiotic metabolismindicates the importance of HO-1 products in cellular functions (Ryter et al. 2006) . In fact, CO was shown to have antiapoptotic, anti-inflammatory, and antiproliferative effects (Ryter et al. 2006 ).
In addition, CO was found to augment IL-10 release (Lee & Chau 2002) after stimulation with LPS, suppress TLR4 signaling pathway and inhibit LPSinduced pro-inflammatory cytokine (TNF-α and IL-6) production in murine macrophages RAW264.7 (Otterbein et al. 2000; Pae et al. 2004b) . Lee & Chau (2002) described a potential inter-play between IL-10 and HO-1 in the inhibition of LPSinduced inflammatory responses. IL-10-mediated protection against LPS-induced septic shock in mice was significantly attenuated by co-treatment with the HO-1 inhibitor, zinc protoporphyrin. They suggested that IL-10 and HO-1 activate a positive feedback circuit to amplify the anti-inflammatory response (Lee & Chau 2002) . Another study demonstrated the critical role of HO-1 as a mediator of the innate immune response by showing the function of myeloid HO-1 in the regulation of IFN-β production (Tzima et al. 2009 ).
Heme oxygenase-1 and tumor growth
On the other hand, inhibition of HO-1 function has a potent anticarcinogenic influence. Interestingly, expression of HO-1 is usually increased in tumors, compared with surrounding healthy tissues. This was shown in lymphosarcoma, adenocarcinoma, hepatoma, glioblastoma, melanoma, prostate cancers, Kaposi sarcoma, squamous carcinoma, pancreatic cancer, and in brain tumors (Berberat et al. 2005; Sass et al. 2008) .
In hepatocellular carcinomas, downmodulation of HO-1 resulted in increased tumor cell damage and apoptosis, reduced proliferation and reduced angiogenesis (Sass et al. 2008) . The influence of HO-1 on the proliferation of cancer cells has been supported by results of experiments performed in animal models. High HO-1 levels from either pharmacologic or genetic manipulation were associated with faster tumor growth, bigger volumes of nodules, and numerous cancer cells. This has been shown for pancreatic cancer, angioma, and melanoma (Sunamura et al. 2003) . In fact, the role of HO-1 in carcinogenesis has not yet been well defined, and there are contradicting reports regarding HO-1 role in tumor progression . In bladder cancer, HO-1 was significantly associated with higher grade and multiple tumors (Yim et al. 2011) , and in lung cancer, it was demonstrated that HO-1 protein is upregulated in epithelial malignant cells in non-small cell lung cancer (NSCLC) and its expression is associated with higher stages of the disease (Degese et al. 2012) . Whereas in colorectal cancer, expression of HO-1 was associated with a better prognosis and longer survival time (Becker et al. 2007 ). It is important to note that the role of HO-1 in tumor progression could be due to the effect of HO-1 on regulatory T cells (Tregs). Multiple reports have shown that CD4 + CD25 + Tregs do not only play a role in the maintenance of immunotolerance but that Tregs are also potent inhibitors of antitumor immune responses in mice. Tregs were shown to have a negative impact on the generation of tumor-specific cytotoxic T cells (Onizuka et al. 1999; Wada et al. 1999; Steitz et al. 2001) . Depletion of Tregs improved the T cell-mediated immunity and significantly increased immunity against various syngeneic tumors in mice (Onizuka et al. 1999; Wada et al. 1999; Steitz et al. 2001) . The number of CD4 + CD25 + regulatory T cells has been reported to increase in peripheral blood of cancer patients. These Tregs showed potent immunosuppressive activity as demonstrated by the ability to suppress the proliferation of CD4 + CD25 − T cells and inhibit NK-cell-mediated cytotoxicity (Becker et al. 2007) .
Tregs are characterized by the expression of a member of the forkhead/winged-helix transcription factors, FOXP3, which is the main regulator gene for the development and function of Tregs (Hori et al. 2003; Yagi et al. 2004 ). The anti-inflammatory effect of HO-1 could be contributed to the ability of HO-1 to induce foxP3. It was reported that HO-1 can mediate an antiinflammatory effect by upregulation of foxp3 in CD4 +
CD25
+ Tregs as well as IL-10 and membrane-bound TGF-β1 (Xia et al. 2007 ).
Heme oxygenase-1 and viral replication
Besides its hepatoprotective effect, HO-1 showed a pronounced antiviral activity in HCV infection. It is established now that HCV is a major cause of chronic hepatitis, progressive liver fibrosis and cirrhosis (Thomas et al. 2000) . In hepatitis B virus (HBV) infection, it has been suggested that induction of HO-1 might be a novel therapeutic option for inflammatory flares of hepatitis B (Protzer et al. 2007 ). Using animal model, specific induction of HO-1 by CoPP-IX significantly reduced the levels of the viral HBV core protein via reduction of HBV core protein stability in cell cultures of stably transfected hepatoma cells (Protzer et al. 2007) .
Our laboratory has investigated the possible role of HO-1 in HCV infection. Our work on liver biopsies from HCV infected patients showed clearly that the ability of infected liver cells to respond to HCV infection may be significantly impaired (Abdalla et al. 2004) . The presence of HCV not only downregulated HO-1, but also prevented the upregulation of major antioxidant enzymes, such as manganese superoxide dismutase and catalase (Abdalla et al. 2004 ). This finding has opened the door for bigger questions regarding the mechanism(s) by which HCV proteins can impair the defense mechanisms in hepatocytes, which render them more susceptible to the injurious effects of ROS and RNS associated with inflammation induced by the infection. The other interesting finding is that other viral infection (HBV) and autoimmune hepatitis could induce HO-1 expression in hepatocytes (Abdalla et al. 2004) . This makes the observation of HO-1 downregulation unique to HCV proteins only. To further study the role of HCV proteins in liver disease and their effect on HO-1 and other antioxidant enzymes, we studied these protein in an in vitro system (Abdalla et al. 2005) . The expression of non-structural proteins HCV could induce some antioxidant enzymes and HO-1 (Abdalla et al. 2005) , whereas, the expression of HCV-core protein reduced the HO-1 level in hepatocytes (Abdalla et al. 2005) . Therefore, the HO-1 reduction in HCV-infected liver samples could be due to the effect of structural-HCV proteins and in particular the HCV-core protein (Abdalla et al. 2005) . In another study, our lab has studied the effect of HO-1 overexpression on HCV replication in Full-length or non-structural replicons. Our results showed that HO-1 overexpression decreased HCV RNA replication in both full-length and non-structural replicons without affecting cellular growth or DNA synthesis. This was reversed in both replicon systems with HO-1 siRNA knockdown (Zhu et al. 2008 ). This clearly shows the antiviral role of HO-1 in hepatocytes (Zhu et al. 2008) . Our lab and others investigated the role of HO-1 products; carbon monoxide, iron and biliverdin on HCV replication (Hou et al. 2009; Lehmann et al. 2010; Zhu et al. 2010) . Interestingly, biliverdin seems to contribute to the antiviral activity of HO-1. Biliverdin was shown to interfere with HCV replication, and specifically, by inhibiting HCV NS3/4A protease. Moreover, biliverdin exerts its effect by inducing the expression of antiviral interferons, such as interferon α2 and α17 (Lehmann et al. 2010; Zhu et al. 2010) . It is clear that HO-1 products have inhibitory effect on HCV. We think that the HCV have developed the ability to inhibit HO-1 induction to avoid these products and to avoid other antiinflammatory cytokines associated with HCV infection. By doing so, HCV can cause more tissue damage and stay away from antiviral factors (Fig. 2) .
In conclusion, the cytoprotective, antioxidative and antiapoptotic effects of HO-1 make it very important for liver tissue. The choice between inducing and inhibiting HO-1 might be critical and should be carefully decided. Therefore, enhancing the HO-1 expression and HO activity will then increase availability of HO-1 products that show anti-HCV effect, eliminate increased ROS and protect cells from injury. This strategy could be considered when liver damage during bacterial sepsis is present, but not when other kind of infections are involved, especially if are also implicated in liver carcinogenic mechanisms (HBV and HCV infections) . In this case, hepatocellular carcinomas is one of the possible outcomes, and manipulating HO-1 expression might have a negative effect, enhance tumor growth and the development of cancer.
